FDA panel wants changes to Avandia safety measures
WASHINGTON (AP) — Federal health experts are recommending changes to safety restrictions on former blockbuster diabetes pill Avandia, in light of a new analysis suggesting that the drug may not increase the risk of heart attack as previously believed.